The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures
- PMID: 3155524
- DOI: 10.1210/jcem-60-2-361
The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures
Abstract
The purpose of this study was to examine the influence of altered prednisolone kinetics in patients with the nephrotic syndrome and women taking oral contraceptive steroids on mixed lymphocyte cultures (MLC). After oral and iv prednisolone treatment, blood samples were collected over 24 h. The area under the plasma concentration vs. time curve (AUC) of unbound, transcortin- bound, and albumin-bound prednisolone was determined. All plasma samples were incubated with MLCs, and the area under the inhibition vs. time curve of the MLC (AUIC), a measure of the effect over time, was calculated. The steroid concentrations required to produce half-maximal inhibition (EC50) were calculated. The 10 women taking oral contraceptives had higher AUCs of unbound and transcortin-bound prednisolone than the 10 normal subjects. The mean biological effect (AUIC value) was more pronounced in women taking contraceptive steroids. An analysis of the concentration-response curves revealed that the EC50 values of total, but not unbound, prednisolone were higher in women taking contraceptives. Compared with the normal subjects, the 9 nephrotic patients had lower total and comparable unbound AUCs of prednisolone. The AUIC values were higher whereas the EC50 values of unbound and total prednisolone were lower in the nephrotic patients. These findings indicate that the increased steroid effect in women taking oral contraceptives is explained by higher concentrations of prednisolone, while the increased effect in nephrotic patients is not attributable to the abnormal kinetics or protein binding of prednisolone.
Similar articles
-
Clinical pharmacokinetics of prednisone and prednisolone.Clin Pharmacokinet. 1990 Aug;19(2):126-46. doi: 10.2165/00003088-199019020-00003. Clin Pharmacokinet. 1990. PMID: 2199128 Review.
-
Prednisolone disposition and protein binding in oral contraceptive users.J Clin Endocrinol Metab. 1983 Apr;56(4):702-9. doi: 10.1210/jcem-56-4-702. J Clin Endocrinol Metab. 1983. PMID: 6833459
-
Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens.J Clin Endocrinol Metab. 1986 Jan;62(1):234-7. doi: 10.1210/jcem-62-1-234. J Clin Endocrinol Metab. 1986. PMID: 2999180
-
Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.J Immunol. 1984 Nov;133(5):2479-87. J Immunol. 1984. PMID: 6237151
-
Effects of oral contraceptive agents and sex steroids on carbohydrate metabolism.Annu Rev Med. 1972;23:429-38. doi: 10.1146/annurev.me.23.020172.002241. Annu Rev Med. 1972. PMID: 4566489 Review.
Cited by
-
The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.Br J Clin Pharmacol. 1986 Feb;21(2):183-9. doi: 10.1111/j.1365-2125.1986.tb05173.x. Br J Clin Pharmacol. 1986. PMID: 3954934 Free PMC article.
-
Clinical pharmacokinetics of prednisone and prednisolone.Clin Pharmacokinet. 1990 Aug;19(2):126-46. doi: 10.2165/00003088-199019020-00003. Clin Pharmacokinet. 1990. PMID: 2199128 Review.
-
Role of altered prednisolone-specific lymphocyte sensitivity in chronic renal failure as a pharmacodynamic marker of acute allograft rejection after kidney transplantation.Eur J Clin Pharmacol. 1991;41(5):417-23. doi: 10.1007/BF00626362. Eur J Clin Pharmacol. 1991. PMID: 1761068
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials